Tryp Therapeutics Inc.

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
Jull, Gage Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
86.37
Quantity 64,301 -3.4%
Value CA$3,250,835
1.5
Jull, Gage Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
348.47
Quantity 84,570 -25.1%
Value CA$715,557
1.5
Jull, Gage Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
497.94
Quantity 65,668 -48.1%
Value CA$4,946,028
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2022-10-25 2022-10-19 B Purchase

Director of Issuer

Non-Executive Director
64,301 -3.4%
86.37
CA$3,250,835
64,301 -3.4% 86.37 CA$3,250,835
2022-10-25 2022-10-19 B Purchase

Director of Issuer

Non-Executive Director
84,570 -25.1%
348.47
CA$715,557
84,570 -25.1% 348.47 CA$715,557
2022-10-25 2022-10-11 B Purchase

Director of Issuer

Non-Executive Director
65,668 -48.1%
497.94
CA$4,946,028
65,668 -48.1% 497.94 CA$4,946,028
Explore more

More insider trading research around Tryp Therapeutics Inc.